PrecisionLife licenses University of Oxford data to discover treatments for endometriosis

Presse/medie

Beskrivelse

PrecisionLife, a techbio company, has partnered with Aalborg University and the University of Oxford to develop personalised treatments for endometriosis. Professor Mette Nyegaard, Professor of Personalised Medicine at Aalborg University, presented an analysis at the 15th World Congress on Endometriosis, identifying the first biological subtypes of the disease. Nyegaard states: "Through the FEMaLe Projects collaboration with PrecisionLife, we have accomplished a significant milestone by stratifying endometriosis patients using genetic insights." (Summary provided by Infomedia) Sources: One Nucleus, 29-06-2023 The BioIndustry Association, 29-06-2023

Periode29 jun. 2023

Mediedækning

2

Mediedækning